KSQ Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-01. The offering totals $80.6M, of which $80.6M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| DAVID A BERRY, M.D., PH.D. | Director | CAMBRIDGE, MA |
| Alan L Crane | Director | Cambridge, MA |
| JAMES L GILBERT | Director | CAMBRIDGE, MA |
| GEORGE L GOLUMBESKI | Director | CAMBRIDGE, MA |
| DAVID P MEEKER, M.D. | Director | CAMBRIDGE, MA |
| RICHARD A MOSCICKI, PH.D. | Director | CAMBRIDGE, MA |
| DAVID P MEEKER, M.D. | Executive Officer | CAMBRIDGE, MA |
| FRANK P STEGMEIER, PH.D. | Executive Officer | CAMBRIDGE, MA |
| JOHN P TRZUPEK, PH.D. | Executive Officer | CAMBRIDGE, MA |